Primary aldosteronism (PA) causes cardiovascular damage in excess to the blood pressure elevation, but there are no prospective studies proving a worse long-term prognosis in adrenalectomized and medically treated patients. We have, therefore, assessed the outcome of PA patients according to treatment mode in the PAPY study (Primary Aldosteronism Prevalence in Hypertension) patients, 88.8% of whom were optimally treated patients with primary (essential) hypertension (PH), and the rest had PA and were assigned to medical therapy (6.4%) or adrenalectomy (4.8%). Total mortality was the primary end point; secondary end points were cardiovascular death, major adverse cardiovascular events, including atrial fibrillation, and total cardiovascular events. Kaplan-Meier and Cox analysis were used to compare survival between PA and its subtypes and PH patients. After a median of 11.8 years, complete follow-up data were obtained in 89% of the 1125 patients in the original cohort. Only a trend (P=0.07) toward a worse death-free survival in PA than in PH patients was observed. However, at both univariate (90.0% versus 97.8%; P=0.002) and multivariate analyses (hazard ratio, 1.82; 95% confidence interval, 1.08-3.08; P=0.025), medically treated PA patients showed a lower atrial fibrillation-free survival than PH patients. By showing that during a long-term follow-up adrenalectomized aldosterone-producing adenoma patients have a similar long-term outcome of optimally treated PH patients, whereas, at variance, medically treated PA patients remain at a higher risk of atrial fibrillation, this large prospective study emphasizes the importance of an early identification of PA patients who need adrenalectomy as a key measure to prevent incident atrial fibrillation.

Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term

Maccario, Mauro;
2018

Abstract

Primary aldosteronism (PA) causes cardiovascular damage in excess to the blood pressure elevation, but there are no prospective studies proving a worse long-term prognosis in adrenalectomized and medically treated patients. We have, therefore, assessed the outcome of PA patients according to treatment mode in the PAPY study (Primary Aldosteronism Prevalence in Hypertension) patients, 88.8% of whom were optimally treated patients with primary (essential) hypertension (PH), and the rest had PA and were assigned to medical therapy (6.4%) or adrenalectomy (4.8%). Total mortality was the primary end point; secondary end points were cardiovascular death, major adverse cardiovascular events, including atrial fibrillation, and total cardiovascular events. Kaplan-Meier and Cox analysis were used to compare survival between PA and its subtypes and PH patients. After a median of 11.8 years, complete follow-up data were obtained in 89% of the 1125 patients in the original cohort. Only a trend (P=0.07) toward a worse death-free survival in PA than in PH patients was observed. However, at both univariate (90.0% versus 97.8%; P=0.002) and multivariate analyses (hazard ratio, 1.82; 95% confidence interval, 1.08-3.08; P=0.025), medically treated PA patients showed a lower atrial fibrillation-free survival than PH patients. By showing that during a long-term follow-up adrenalectomized aldosterone-producing adenoma patients have a similar long-term outcome of optimally treated PH patients, whereas, at variance, medically treated PA patients remain at a higher risk of atrial fibrillation, this large prospective study emphasizes the importance of an early identification of PA patients who need adrenalectomy as a key measure to prevent incident atrial fibrillation.
71
4
585
591
http://hyper.ahajournals.org/
adenoma; aldosterone; atrial fibrillation; hyperaldosteronism; longitudinal study; Adult; Aftercare; Female; Humans; Italy; Longitudinal Studies; Male; Middle Aged; Prognosis; Prospective Studies; Renin-Angiotensin System; Time; Adrenalectomy; Antihypertensive Agents; Atrial Fibrillation; Conservative Treatment; Hyperaldosteronism; Hypertension
Rossi, Gian Paolo; Maiolino, Giuseppe; Flego, Alberto; Belfiore, Anna; Bernini, Giampaolo; Fabris, Bruno; Ferri, Claudio; Giacchetti, Gilberta; Letizia, Claudio; Maccario, Mauro; Mallamaci, Francesca; Muiesan, Maria Lorenza; Mannelli, Massimo; Negro, Aurelio; Palumbo, Gaetana; Parenti, Gabriele; Rossi, Ermanno; Mantero, Franco
File in questo prodotto:
File Dimensione Formato  
HYPERTENSIONAHA.117.10596.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 178.48 kB
Formato Adobe PDF
178.48 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
rossi et al.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 237.44 kB
Formato Adobe PDF
237.44 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1693179
Citazioni
  • ???jsp.display-item.citation.pmc??? 35
  • Scopus 100
  • ???jsp.display-item.citation.isi??? 101
social impact